Edwards Lifesciences Corp Stock Buy Hold or Sell Recommendation
| EW Stock | USD 69.29 1.34 1.97% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Edwards Lifesciences Corp is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Edwards Lifesciences Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Edwards Lifesciences Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Edwards Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Edwards and provide practical buy, sell, or hold advice based on investors' constraints. Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
Edwards |
Execute Edwards Lifesciences Buy or Sell Advice
The Edwards recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Edwards Lifesciences Corp. Macroaxis does not own or have any residual interests in Edwards Lifesciences Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Edwards Lifesciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Edwards Lifesciences Trading Alerts and Improvement Suggestions
| Edwards Lifesciences generated a negative expected return over the last 90 days | |
| Edwards Lifesciences is unlikely to experience financial distress in the next 2 years | |
| Over 89.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from massdevice.com: Signum Surgical appoints CEO to spearhead BioHealx launch |
Edwards Lifesciences Returns Distribution Density
The distribution of Edwards Lifesciences' historical returns is an attempt to chart the uncertainty of Edwards Lifesciences' future price movements. The chart of the probability distribution of Edwards Lifesciences daily returns describes the distribution of returns around its average expected value. We use Edwards Lifesciences Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Edwards Lifesciences returns is essential to provide solid investment advice for Edwards Lifesciences.
| Mean Return | -0.08 | Value At Risk | -1.97 | Potential Upside | 2.94 | Standard Deviation | 1.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Edwards Lifesciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Edwards Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Edwards Lifesciences, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Edwards Lifesciences Corp back and forth among themselves.
| Shares | Jennison Associates Llc | 2024-12-31 | 7.5 M | Ninety One Uk Limited | 2024-12-31 | 7.2 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 7.1 M | Deutsche Bank Ag | 2024-12-31 | 6.9 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 6.5 M | Northern Trust Corp | 2024-12-31 | 6.5 M | Marshall Wace Asset Management Ltd | 2024-12-31 | 5.8 M | Wellcome Trust Ltd | 2024-12-31 | 4.8 M | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 4.6 M | Vanguard Group Inc | 2024-12-31 | 69.1 M | Blackrock Inc | 2024-12-31 | 54.5 M |
Edwards Lifesciences Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (120.6M) | 19M | (213.4M) | (289M) | (256.1M) | (243.3M) | |
| Free Cash Flow | 647M | 1.4B | 953.4M | 629.5M | 289.9M | 439.5M | |
| Depreciation | 107.2M | 134.8M | 139.6M | 144.9M | 155.2M | 85.3M | |
| Other Non Cash Items | 38.3M | (119M) | 105.8M | 7.5M | (3.4B) | (3.2B) | |
| Capital Expenditures | 407.3M | 329.8M | 264.8M | 266.3M | 252.4M | 151.7M | |
| Net Income | 823.4M | 1.5B | 1.5B | 1.4B | 4.2B | 4.4B | |
| Change In Cash | 15.8M | (332.8M) | (94.8M) | 375.4M | 1.9B | 2.0B | |
| End Period Cash Flow | 1.2B | 867.4M | 772.6M | 1.1B | 3.1B | 3.2B | |
| Dividends Paid | 140.5M | 158.6M | 146.4M | 169.9M | 152.9M | 233.1M | |
| Investments | (101.7M) | (1.3B) | 252.3M | 254.4M | 2.3B | 2.4B | |
| Change Receivables | (88M) | 41.9M | (91.1M) | (84.1M) | (75.7M) | (71.9M) | |
| Net Borrowings | (10M) | (800K) | (1.8M) | (200K) | (180K) | (171K) | |
| Change To Netincome | 198.2M | 53.3M | (79.6M) | (49.1M) | (56.5M) | (53.6M) |
Edwards Lifesciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Edwards Lifesciences or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Edwards Lifesciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Edwards stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 1.64 | |
Ir | Information ratio | 0.03 |
Edwards Lifesciences Volatility Alert
Edwards Lifesciences Corp exhibits very low volatility with skewness of 1.71 and kurtosis of 5.4. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Edwards Lifesciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Edwards Lifesciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Edwards Lifesciences Fundamentals Vs Peers
Comparing Edwards Lifesciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Edwards Lifesciences' direct or indirect competition across all of the common fundamentals between Edwards Lifesciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Edwards Lifesciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Edwards Lifesciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Edwards Lifesciences to competition |
| Fundamentals | Edwards Lifesciences | Peer Average |
| Return On Equity | 0.17 | -0.31 |
| Return On Asset | 0.0826 | -0.14 |
| Profit Margin | 0.77 % | (1.27) % |
| Operating Margin | 0.26 % | (5.51) % |
| Current Valuation | 37 B | 16.62 B |
| Shares Outstanding | 587.9 M | 571.82 M |
| Shares Owned By Insiders | 0.91 % | 10.09 % |
| Shares Owned By Institutions | 88.93 % | 39.21 % |
| Number Of Shares Shorted | 8.49 M | 4.71 M |
| Price To Earning | 32.77 X | 28.72 X |
| Price To Book | 4.03 X | 9.51 X |
| Price To Sales | 7.34 X | 11.42 X |
| Revenue | 5.44 B | 9.43 B |
| Gross Profit | 4.32 B | 27.38 B |
| EBITDA | 1.72 B | 3.9 B |
| Net Income | 4.17 B | 570.98 M |
| Cash And Equivalents | 769 M | 2.7 B |
| Cash Per Share | 2.81 X | 5.01 X |
| Total Debt | 700 M | 5.32 B |
| Debt To Equity | 0.11 % | 48.70 % |
| Current Ratio | 3.83 X | 2.16 X |
| Book Value Per Share | 16.99 X | 1.93 K |
| Cash Flow From Operations | 542.3 M | 971.22 M |
| Short Ratio | 1.95 X | 4.00 X |
| Earnings Per Share | 2.34 X | 3.12 X |
| Price To Earnings To Growth | 5.35 X | 4.89 X |
| Target Price | 80.42 | |
| Number Of Employees | 15.8 K | 18.84 K |
| Beta | 1.12 | -0.15 |
| Market Capitalization | 39.95 B | 19.03 B |
| Total Asset | 13.06 B | 29.47 B |
| Retained Earnings | 13.17 B | 9.33 B |
| Working Capital | 4.78 B | 1.48 B |
Note: Disposition of 4559 shares by Andrew Dahl of Edwards Lifesciences at 87.62 subject to Rule 16b-3 [view details]
Edwards Lifesciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Edwards . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 96810.42 | |||
| Daily Balance Of Power | 0.7128 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 68.72 | |||
| Day Typical Price | 68.91 | |||
| Price Action Indicator | 1.24 | |||
| Period Momentum Indicator | 1.34 |
About Edwards Lifesciences Buy or Sell Advice
When is the right time to buy or sell Edwards Lifesciences Corp? Buying financial instruments such as Edwards Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Edwards Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hedge Favorites Thematic Idea Now
Hedge Favorites
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.